India’s Central Drugs Standard Control Organisation (CDSCO) says Pfizer officials failed to turn up to meetings after the company’s application was made in early December and wants India to order its COVID-19 vaccines without any local trials.
- EXPLOSIVE: Here’s what was uncovered in Hunter Biden’s iCloud Hack
- MAJOR PEER REVIEWED STUDY: Moderna Vaccine Increases Myocarditis Risk By 44 Times In Young Adults
- MUST READ: High Level International Bankers Simulate The Collapse Of Global Financial System
- BIG STORY: Wuhan Lab Isolated Monkeypox Strain In 2020
- EXPLOSIVE: Ukraine Biolabs Used Fever Carrying Mosquitoes To Spark Dengue Pandemic In Cuba
Pfizer was the first company to seek emergency-use authorisation (EUA) for a COVID-19 vaccine in India.
But India’s Central Drugs Standard Control Organisation (CDSCO) says Pfizer officials failed to turn up to meetings after the company’s application was made in early December.
The regulator has also declined to accept the company’s request for approval without a small local trial on the vaccine’s safety and immunogenicity for Indians, Reuters has reported.
“The data collected has been endorsed by various regulatory agencies (including the most evolved) and they have given EUA [based on] … that data,” Pfizer said in an emailed response to questions, including on India’s demand for a local trial.
Subscribe to GreatGameIndia
According to data from the Vaccine Adverse Event Reporting System (VAERS), atleast 181 Americans died from COVID-19 vaccines in just 2 Weeks.
As reported by GreatGameIndia earlier, Pfizer has paid $2.3 billion in the largest healthcare fraud settlement in history to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products.
Even, the US government paid over $57 million in compensation for vaccine injuries and deaths till March 2020 alone.
For latest updates on the outbreak check out our Coronavirus Coverage.